Sonic Clinical Trials recognise the uncertainty that exists relating to the potential impact of the COVID-19 virus on clinical trials in the coming months and also recognise that no business will be immune from its impacts. Our management team continue to closely monitor the impact of the COVID-19 pandemic, meeting daily to ensure the health and well-being of our staff and business continuity across all operational, site support, laboratory and quality functions.
The Sonic team understands the nature of the services we provide as far as supply of study-specific blood collection kits and laboratory testing services are critical to positive outcomes for your patients enrolled in a clinical trial. We are in close communication with our logistics and research partners including direct to patient services to facilitate ongoing study activity, oversight and management by exploring alternative solutions to minimise delay in delivering supplies and biological samples.
As this is a very fluid situation and we will continue to provide updates to our clients via our website to ensure that you have the information required to make decisions regarding the impact of the COVID-19 pandemic. Our dedicated clinical trials team remain available to speak with you further should it be required.